Lisinopril
Product Images NDC 21695-345

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 21695-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Picture Of Lisinopril Chemical Structure. (81210afd 6505 4d38 Ab83 E276ee4ce144 01)

Chemical structure of Lisinopril displayed as a standard skeletal formula with atoms, bonds, and functional groups, including two water molecules (dihydrate).*

FDA Label Image

Picture Of Lisinopril Table 1 (81210afd 6505 4d38 Ab83 E276ee4ce144 02)

Table showing the percent of patients experiencing various side effects in controlled studies comparing Lisinopril, Lisinopril/Hydrochlorothiazide, and placebo. Side effects are categorized by body system, such as body as a whole, cardiovascular, digestive, musculoskeletal, nervous/psychiatric, respiratory, skin, and urogenital, with incidence and discontinuation rates listed for each treatment group.*

FDA Label Image

Picture Of Lisinopril Table 2 (81210afd 6505 4d38 Ab83 E276ee4ce144 03)

A data table presenting the incidence of adverse events leading to discontinuation during 12-week controlled trials comparing Lisinopril (n=407) and placebo (n=155). Categories include Body as a Whole, Cardiovascular, Digestive, Nervous/Psychiatric, Respiratory, and Skin, with specific events like chest pain, hypotension, dizziness, and rash listed alongside their corresponding percentages and standard deviations for each group.*

FDA Label Image

Picture Of Lisinopril Table 3 (81210afd 6505 4d38 Ab83 E276ee4ce144 04)

A data table showing the percentage of patients experiencing various events comparing high dose and low dose groups of Lisinopril. Events listed include dizziness, hypotension, increased creatinine, hyperkalemia, increased NPN, and syncope with corresponding percentages for each dose group.*

FDA Label Image

Picture Of Lisinopril Table 4 (81210afd 6505 4d38 Ab83 E276ee4ce144 05)

A data table showing initial dosing guidance for Lisinopril according to renal status and creatinine clearance levels (mL/min). It categorizes dosing for normal to mild impairment, moderate to severe impairment, and dialysis patients, indicating doses from 10 mg/day to 2.5 mg/day with notes on dosage adjustment based on blood pressure response and warnings about anaphylactoid reactions.*

FDA Label Image

Lisinopril 2.5mg (81210afd 6505 4d38 Ab83 E276ee4ce144 06)

Lisinopril 2.5 mg tablets label showing 90 tablets per package. The label includes the NDC 21695-345-90, mentions the product is Rx only, and describes the tablets as white to off-white, round, biconvex, uncoated with "LUPIN" debossed on one side and "2.5" on the other. The label lists the manufacturer as Lupin Limited Goa, India, and the packager as Physician Partner in Thousand Oaks, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.